IP Library Granted Patent US 7,632,823
Granted Patent B2
US 7,632,823 · App. 11/293,629 · Granted Dec 15, 2009

Compositions of tRNA and uses thereof

Assignee: Ambrx, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,632,823
App. No.
11/293,629
Granted
Dec 15, 2009
Kind
B2
Abstract

Compositions and methods of producing components of protein biosynthetic machinery that include orthogonal tRNA's, orthogonal aminoacyl-tRNA synthetases, and orthogonal pairs of tRNA's/synthetases are provided. Methods for identifying these orthogonal pairs are also provided along with methods of producing proteins using these orthogonal pairs.

Claims (43)

1. A composition comprising a tRNA having the nucleic acid sequence selected from the group consisting of SEQ ID NOs: 1, 2, and 3, and the full length complementary polynucleotide sequence that encodes SEQ ID NO: 1, 2 and 3 in a buffer.

2. The composition of claim 1 , wherein said tRNA is aminoacylated.

3. The composition of claim 2 , wherein said tRNA is aminoacylated with a non-naturally encoded amino acid.

4. The composition of claim 3 , wherein said non-naturally encoded amino acid is para-acetylphenylalanine.

5. The composition of claim 2 , wherein said tRNA is chemically aminoacylated.

6. The composition of claim 2 , wherein said tRNA is enzymatically aminoacylated.

7. The composition of claim 6 , wherein said tRNA is enzymatically aminoacylated by an aminoacyl tRNA synthetase.

8. The composition of claim 6 , wherein said tRNA is enzymatically aminoacylated by a ribozyme.

9. The composition of claim 1 , further comprising an aminoacyl tRNA synthetase, wherein the tRNA is aminoacylated with an amino acid.

10. The composition of claim 9 , wherein said amino acid is a non-naturally encoded amino acid.

11. The composition of claim 10 , wherein said non-naturally encoded amino acid is para-acetylphenylalanine.

12. The composition of claim 1 , wherein the tRNA is derived from an archael tRNA.

13. The composition of claim 1 , wherein the tRNA is derived from M. janneschii.

14. The composition of claim 1 , further comprising a translation system.

15. The composition of claim 14 , wherein said translation system is a cell-free translation system.

16. The composition of claim 14 , wherein said translation system is a cell lysate.

17. The composition of claim 14 , wherein said translation system is a reconstituted system.

18. The composition of claim 14 , wherein said translation system is a cellular translation system.

19. A cell comprising a translation system, wherein the translation system comprises the tRNA of claim 1 .

20. The cell of claim 19 , wherein the cell is a eukaryotic cell.

21. The cell of claim 20 , wherein the eukaryotic cell is a yeast cell.

22. The cell of claim 20 , wherein the eukaryotic cell is a fungal cell.

23. The cell of claim 20 , wherein the eukaryotic cell is a mammalian cell.

24. The cell of claim 20 , wherein the eukaryotic cell is an insect cell.

25. The cell of claim 20 , wherein the eukaryotic cell is a plant cell.

26. The cell of claim 19 , wherein the cell is a non-eukaryotic cell.

27. The cell of claim 26 , wherein the non-eukaryotic cell is an E. coli cell.

28. The cell of claim 19 , further comprising a polynucleotide encoding a polypeptide of interest, wherein the polynucleotide comprises a selector codon that is recognized by the tRNA.

29. The cell of claim 28 , wherein said polypeptide of interest is human growth hormone.

30. An E. coli cell comprising the tRNA of claim 1 .

31. A yeast cell comprising the tRNA of claim 1 .

32. A fungal cell comprising a tRNA of claim 1 .

33. A mammalian cell comprising a tRNA of claim 1 .

34. An insect cell comprising a tRNA of claim 1 .

35. A plant cell comprising a tRNA of claim 1 .

36. A vector comprising a polynucleotide encoding a tRNA having the nucleic acid sequence selected from the group consisting of SEQ ID NO: 1, 2, and 3, and the full-length complementary polynucleotide sequence that encodes SEQ ID NO: 1, 2 and 3.

37. The vector of claim 36 , wherein the vector comprises a plasmid, a cosmid, a phage, or a virus.

38. The vector of claim 36 , wherein the vector is an expression vector.

39. A cell comprising the vector of claim 36 .

40. A method of producing a polypeptide in a cell with a selected amino acid at a specified position, the method comprising: growing, in an appropriate medium, the cell, where the cell comprises a nucleic acid that comprises at least one selector codon and encodes a polypeptide; and, providing the selected amino acid; wherein the cell further comprises: an orthogonal tRNA (O-tRNA) that functions in the cell and recognizes the selector codon having the amino acid sequence selected from the group consisting of SEQ ID NO: 1, 2, 3, and the full-length complementary polynucleotide sequence that encodes SEQ ID NO: 1, 2 and 3; and, an orthogonal aminoacyl-tRNA synthetase (O-RS), wherein said O-RS aminoacylates the O-tRNA with the selected amino acid.

41. The method of claim 40 wherein said selected amino acid is para-acetyl phenylalanine.

42. The method of claim 40 wherein said polypeptide is human growth hormone.

43. A polynucleotide having a nucleic acid sequence selected from a group consisting of SEQ ID Nos. 1, 2, and 3, and the full-length complementary polynucleotide sequence thereof.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2006
From: TIAN, FENG
To: AMBRX, INC.
Reel/Frame 017541/0498 →
Continuity (2)
Provisional Application 6070936400 · Aug 18, 2005
Related Publication 20080153745A1 · Jun 26, 2008